Health Research Company


generic name is pegloticase

Why is this drug subscribed ?

Pegloticase injection is used to treat ongoing gout (sudden, severe pain, redness, and swelling in one or more joints caused by abnormally high levels of a substance called uric acid in the blood) in adults who cannot take or did not respond to other medications. Pegloticase injection is in a class of medications called PEGylated uric acid specific enzymes. It works by decreasing the amount of uric acid in the body. Pegloticase injection is used to prevent gout attacks, but not to treat them once they occur.

Active Substance: PEGLOTICASE

related condition/diseases:

Krystexxa Available Drugs :

Krystexxa ndc# 54396-801

by Savient Pharmaceuticals, Inc.

INTRAVENOUS INJECTION, SOLUTION with active strength of 8 mg/mL

started marketing at 14/09/2010 .

Krystexxa Search Trends:

News :

Social Buzz

comments powered by Disqus